Historical record - last NADAC publication: 2/22/2017

Product Information

ALFUZOSIN HCL ER 10 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1744 per EA under NDC 65862024901. Its NADAC has been published 170 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Alfuzosin Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ALFUZOSIN HCL ER 10 MG TABLET

Alfuzosin Hydrochloride
$0.1744per EA
High Outlier

Strength

10 mg/1

NDC

65862024901

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

2/22/2017

Active Ingredients

ALFUZOSIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA079060

On Market Since

8/30/2012

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for ALFUZOSIN HCL ER 10 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 27.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1744 per EA
All-time high$0.2665 (Mar 11, 2015)
All-time low$0.1744 (Feb 22, 2017)
Median price$0.2388
Average price$0.2287
Largest weekly change-13.8% (Aug 19, 2015)
Weeks tracked170
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-27.0%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ALFUZOSIN HCL ER 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALFUZOSIN HCL ER 10 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1744 per EA (NDC 65862024901), effective Feb 22, 2017.

How has the price of ALFUZOSIN HCL ER 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has declined 27.0%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ALFUZOSIN HCL ER 10 MG TABLET?

Since Nov 28, 2013, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has ranged from a low of $0.1744 (Feb 22, 2017) to a high of $0.2665 (Mar 11, 2015), with a median of $0.2388 per EA.

Are there cheaper alternatives to ALFUZOSIN HCL ER 10 MG TABLET?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ALFUZOSIN HCL ER 10 MG TABLET, is $0.1074 per EA — about 38% below ALFUZOSIN HCL ER 10 MG TABLET.

Who manufactures ALFUZOSIN HCL ER 10 MG TABLET?

ALFUZOSIN HCL ER 10 MG TABLET (NDC 65862024901) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.